p53 Expression Helps Identify High Risk Oral Tongue Premalignant Lesions and Correlates with Patterns of Invasive Tumour Front and Tumour Depth in Oral Tongue Squamous Cell Carcinoma Cases

  • Viveka, Thangaraj Soundara (Department of Preventive Oncology, Cancer Institute (WIA)) ;
  • Shyamsundar, Vidyarani (Centre for Oral Cancer Prevention Awareness and Research, Sree Balaji Dental College and Hospital) ;
  • Krishnamurthy, Arvind (Department of Surgical Oncology, Cancer Institute (WIA)) ;
  • Ramani, Pratibha (Department of Oral and Maxillofacial Pathology, Saveetha Dental College) ;
  • Ramshankar, Vijayalakshmi (Department of Preventive Oncology, Cancer Institute (WIA))
  • Published : 2016.02.05


Oral tongue squamous cell carcinoma (OTSCC) is the most common oral cancer subtype with a maximum propensity for regional spread. Our objective was to study if p53 expression might have any correlation with aggressive patterns of invasion within oral tongue cancers as well as with the histologically identified degree of oral tongue dysplasia. p53 immunoexpression was studied using immunohistochemistry in early staged OTSCCs (n=155), oral tongue dysplasias, (n=29) and oral tongue normal specimens (n=10) and evaluated for correlations with histological and clinicopathological parameters. Our study (n=194) showed a pattern of p53 expression increasing with different grades of tongue dysplasia to different grades of invasive OTSCC (p=0.000). Among the OTSCC tumours, positive p53 expression was seen in 43.2% (67/155) and a higher p53 labelling index was significantly associated with increased Bryne's grade of the tumour invasive front (p=0.039) and increased tumour depth (p=0.018). Among the OTSCC patients with tobacco habits, (n=91), a higher p53 labelling index was significantly associated with increased risk of local recurrence (p=0.025) and with lymphovascular space involvement (p=0.014). Evaluation of p53 through varying degrees of dysplasia to oral tongue cancer indicates that p53 expression is linked to aggressive features of oral tongue cancers and tongue precancers entailing a closer monitoring in positive cases. Among the OTSCCs, p53 expression is associated with tumour aggressiveness correlating with increased grading of invasive tumour front and tumour depth.


Oral tongue carcinoma;oral tongue dysplasia;p53 expression;increased tumour depth;local recurrence


Supported by : Tamilnadu Dr MGR Medical University


  1. Abbey LM, Kaugars GE, Gunsolley JC, et al (1995). Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 80, 188-91.
  2. Bryne M, Koppang HS, Lilleng R, et al (1992). Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol, 166, 375-81.
  3. Cruz I, Napier SS, van der Waal I, et al (2002). Suprabasal p53 immunoexpression is strongly associated with high grade dysplasia and risk for malignant transformation in potentially malignant oral lesions from Northern Ireland. J Clin Pathol, 55, 98-10
  4. Cruz IB, Snijders PJ, Meijer CJ, et al (1998). p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has a predictive value for developing oral squamous cell carcinoma. J Pathol, 184, 360-8<360::AID-PATH1263>3.0.CO;2-H
  5. Elango JK, Gangadharan P, Sumithra S, et al (2006). Trends of head and neck cancers in urban and rural India. Asian Pac J Cancer Prev, 7, 108-12.
  6. Gupta PC, Mehta FS, Daftary DK, et al (1980). Incidence rates of oral cancer and natural history of oral precancerous lesions in a 10-year follow-up study of Indian villagers. Community Dent Oral Epidemiol, 8, 283-333.
  7. Girod SC, Pfeiffer P, Ries J, et al (1998). Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg, 36, 252-60.
  8. Gorgoulis V, Zoumpourlis V, Rassidakis G, et al (1995). Molecular analysis of p53 gene in laryngeal premalignant and malignant lesions. p53 protein immunohistochemical expression is positively related to proliferating cell nuclear antigen labelling index. Virchows Arch, 426, 339-44.
  9. Hainaut P (2000). TP53 tumor suppressor gene: 20 years (and ten thousand mutations) later. Bull Cancer, 87, 11-8.
  10. Holmstrup P, Vedtofte P, Reibel J, et al (2007). Oral premalignant lesions : is biopsy reliable ? J Oral Pathol Med, 36, 262-6.
  11. Humayun S, Prasad VR (2011) Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study. Natl J Maxillofac Surg, 2, 38-46
  12. Iwasa M, Imamura Y, Noriki S, et al (2001). Immunohistochemical detection of early-stage carcinogenesis of oral leukoplakia by increased DNA-instability and various malignancy markers. Eur J Histochem, 45, 333-46.
  13. Kerpdon D, Rich IS, Reade PC, et al, (1997). Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis, 3, 86-92.
  14. Krishna Rao SV, Mejia G, Roberts-Thomson K, et al (2013). Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pac J Cancer Prev, 14, 5567-77.
  15. Keski-Säntti H, Atula T, Tikka J, et al (2007). Predictive value of histopathologic parameters in early squamous cell carcinoma of oral tongue. Oral Oncol, 3, 1007-13
  16. Krishnamurthy A, Ramshankar V. (2013). Early stage oral tongue cancer among non-tobacco users--an increasing trend observed in a South Indian patient population presenting at a single centre. Asian Pac J Cancer Prev, 14, 5061-5.
  17. Kovesi G, Szende B (2003). Changes in apoptosis and mitotic index, p53 and Ki67 expression in various types of oral leukoplakia. Oncol, 65, 331-6.
  18. Lippman SM, Shin DM, Lee JJ, et al (1995). p53 and retinoid chemoprevention of oral carcinogenesis. Cancer Res, 55, 16-9.
  19. Maddocks OD, Vousden KH (2011). Metabolic regulation by p53. J Mol Med, 89, 237-45
  20. Mehrotra R, Yadav S (2006). Oral squamous cell carcinoma: etiology, pathogenesis and prognostic value of genomic alterations. Indian J Cancer, 43, 60-6.
  21. Mishra A, Meherotra R (2014). Head and neck cancer: global burden and regional trends in India. Asian Pac J Cancer Prev, 15, 537-50.
  22. Moore SR, Johnson NW, Pierce AM, et al (2000). The epidemiology of mouth cancer: a review of global incidence. Oral Dis, 6, 65-74.
  23. Murti PR, Warnakulasuriya KA, Johnson NW, et al (1998). p53 expression in oral precancer as a marker for malignant potential. J Oral Path Med, 27, 191-6.
  24. Nigro JM, Baker SJ, Preisinger AC, et al (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature, 342, 705-8.
  25. Nylander K, Dabelsteen E, Hall PA (2000). The p53 molecule and its prognostic role in squamous cell carcinoma of head and neck. J Oral Path Med, 29, 413-25.
  26. Ogden GR, Kiddie RA, Lunny DP, et al (1992). Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol, 166, 389-94.
  27. Pillay M, Vasudevan DM, Rao CP, et al (2003). p53 expression in oral cancer: observations of a south Indian study. J Exp Clin Cancer Res, 22, 447-51.
  28. Ramshankar V, Soundara VT, Shyamsundar V, et al (2014). Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression. Asian Pac J Cancer Prev, 15, 8351-9.
  29. Rich AM, Kerdpon D, Reade PC. (1995). p53 expression in oral precancer and cancer. Aust Dent J, 44, 103-5.
  30. Saranath D, Tandle AT, Teni TR, et al (1999). p53 inactivation in chewing tobacco induced oral cancers and leukoplakia from India. Oral Oncol, 35, 242-50.
  31. Tan WJ, Chia CS, Tan HK, et al (2012). Prognostic significance of invasion depth in oral tongue squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec, 74, 264-70
  32. Tsantoulis PK, Kastrinakis NG, Tourvas AD, et al (2007). Advances in the biology of oral cancer. Oral Oncol, 43, 523-34
  33. Van Houten VMM, Leemans K, Alain Kummer et al (2004). Molecular Diagnosis of surgical margins and local recurrence in head and neck cancer patients : A Prospective Study. Clinical Cancer Res, 10, 3614-20.
  34. Warnakulasuriya KA and Johnson NW (1992). Expression of p53 mutant nuclear phosphorylation in oral carcinoma and potentially malignant oral lesions. J Oral Pathol Med, 21, 404-8.
  35. Yan JJ, Tzeng CC, Jin YT (1996). Overexpression of p53 protein in squamous cell carcinoma of the buccal mucosa and tongue in Taiwan- an immunohistochemical and clinicopathological study. J Oral Pathol Med, 25, 55-9.
  36. Yeole BB, Kurkure AP, Sunny L (2011). Cancer survival in Mumbai (Bombay), India, 1992-1999. IARC Sci Publ, 162, 133-42

Cited by

  1. MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion vol.49, pp.5, 2016,
  2. Curcumin inhibits cancer progression through regulating expression of microRNAs vol.39, pp.2, 2017,
  3. Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo vol.39, pp.5, 2017,
  4. Global Quantitative Proteomics reveal Deregulation of Cytoskeletal and Apoptotic Signalling Proteins in Oral Tongue Squamous Cell Carcinoma vol.8, pp.1, 2018,
  5. CRBP-1 over-expression is associated with poor prognosis in tongue squamous cell carcinoma vol.18, pp.1, 2018,